Intangible Assets, Net - Schedule of Components of Intangible Assets (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Intangible Asset, Finite-Lived [Line Items] | ||
| Gross Carrying Amount | $ 101,099 | $ 87,664 |
| Accumulated Amortization | (15,325) | (11,520) |
| Net Carrying Value | 85,774 | 76,144 |
| Commercial products | ||
| Intangible Asset, Finite-Lived [Line Items] | ||
| Gross Carrying Amount | 96,523 | 83,203 |
| Accumulated Amortization | (11,511) | (8,056) |
| Net Carrying Value | 85,012 | 75,147 |
| Commercial products | Tisotumab Vedotin | ||
| Intangible Asset, Finite-Lived [Line Items] | ||
| Net Carrying Value | 10,000 | |
| Software | ||
| Intangible Asset, Finite-Lived [Line Items] | ||
| Gross Carrying Amount | 4,576 | 4,461 |
| Accumulated Amortization | (3,814) | (3,464) |
| Net Carrying Value | $ 762 | $ 997 |
| X | ||||||||||
- Definition Amount of accumulated amortization of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|